Correlation Between Eurobio Scientific and Abivax SA
Can any of the company-specific risk be diversified away by investing in both Eurobio Scientific and Abivax SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurobio Scientific and Abivax SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurobio Scientific SA and Abivax SA, you can compare the effects of market volatilities on Eurobio Scientific and Abivax SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurobio Scientific with a short position of Abivax SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurobio Scientific and Abivax SA.
Diversification Opportunities for Eurobio Scientific and Abivax SA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Eurobio and Abivax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eurobio Scientific SA and Abivax SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abivax SA and Eurobio Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurobio Scientific SA are associated (or correlated) with Abivax SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abivax SA has no effect on the direction of Eurobio Scientific i.e., Eurobio Scientific and Abivax SA go up and down completely randomly.
Pair Corralation between Eurobio Scientific and Abivax SA
If you would invest 2,495 in Eurobio Scientific SA on September 9, 2024 and sell it today you would earn a total of 70.00 from holding Eurobio Scientific SA or generate 2.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Eurobio Scientific SA vs. Abivax SA
Performance |
Timeline |
Eurobio Scientific |
Abivax SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eurobio Scientific and Abivax SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eurobio Scientific and Abivax SA
The main advantage of trading using opposite Eurobio Scientific and Abivax SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurobio Scientific position performs unexpectedly, Abivax SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abivax SA will offset losses from the drop in Abivax SA's long position.Eurobio Scientific vs. Biosynex | Eurobio Scientific vs. Novacyt | Eurobio Scientific vs. Biophytis SA | Eurobio Scientific vs. Intrasense |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamental Analysis View fundamental data based on most recent published financial statements |